The 80-and-over crowd in America is on pace to nearly double in 15 years. And skilled nursing supply? It's shrinking. One landlord owns the buildings no one can afford to rebuild, runs the cleanest book in the sector, and drops Q3 numbers in late October.
Replacing US dollar (Sponsored)
It wasn't voted on.
It wasn't debated in the Senate.
And most Americans have no idea it's even taking place but… President Trump is replacing the U.S. dollar.
The last time this happened it minted an average of 1,300 new millionaires a day for over half a century.
While leaving millions of other folks behind…
Which side will you be on?
Meet the Pick
CareTrust REIT (NYSE: CTRE) is a self-managed REIT that owns skilled nursing facilities, senior housing, and other post-acute healthcare properties.
The model is dead simple. CareTrust owns the dirt and the buildings, signs long-term triple-net leases with regional operators (tenants pick up taxes, insurance, and upkeep), and collects your check every month.
Shares last closed at $38.42 with a market cap of $9.2 billion. Your trailing yield sits near 3.3%. But the headline yield isn't what sets this one apart. It's how they're funding it: fresh capital going out the door at nearly 9%.
Why the Street Keeps Underwriting This Like It's 2023
Healthcare REITs got tossed in the penalty box during the post-COVID staffing meltdown, and Wall Street has a long memory. Analysts still model CareTrust like it's one operator blowup away from a distribution cut. There's your disconnect.
Here's what's actually different now. Skilled nursing occupancy is back near pre-pandemic marks. Operator rent coverage has healed up.
And CareTrust cleaned house on tenant concentration years ago, spreading risk across a much deeper roster of regional operators.
Meanwhile, management is deploying capital at yields that'd make a PE fund blush. You don't pick up assets at 8.7% cash yields in a healthy sector.
You get those numbers because the sector still smells broken, even though the operating story has moved on.
Action: Accumulate CTRE between $36 and $39 ahead of Q3 earnings in late October. Expect another guidance refresh.
Warning Signal Returns (Sponsored)
In 1929, Irving Weiss spotted danger before most of Wall Street saw it coming.
That research process later became the foundation of Weiss Ratings — and now the system is flashing one of its strongest warnings in years.
Their latest briefing explains what could hit the market in the back half of 2026, which popular stocks may be vulnerable, and which lesser-known names they believe could benefit.
See the Stocks to Avoid — and the Ones Weiss Is Watching Now
The Q3 Print Could Force a Repricing
CareTrust already bumped 2026 core FFO guidance once this year. Q3 is the next window to do it again. And the setup favors another raise.
What's feeding through:
$1.5 billion of investments closed year-to-date at a blended 8.7% cash yield
A $540 million pipeline of additional deals in negotiation
Net debt/EBITDA around 1.01x. One of the lowest in the entire REIT universe.
Fresh accretion from mid-year closings that haven't fully hit run-rate yet
Every dollar CareTrust puts out at 8.7% while its cost of capital sits meaningfully lower is pure spread accretion. And because the balance sheet is basically unlevered by REIT standards, management keeps writing checks without diluting you. That's the flywheel the market hasn't priced.
If you want the near-term spark, this is it. A Q3 print carrying higher run-rate FFO plus another guidance bump is the kind of event that forces the sell side to reset targets in a hurry.
Gold Before Change (Sponsored)
In 1971, one Sunday-night announcement changed the dollar almost overnight.
Today, investors are again asking what inflation, policy shifts, and rising central-bank gold demand could mean for retirement savings.
This free guide explains why gold is back in focus, how physical gold can fit into certain retirement strategies, and what some investors are doing to prepare before the next major monetary shift.
See how investors are positioning retirement savings for the next gold move.
*Reagan Gold Group does not provide financial, legal, or tax advice. This information is for educational purposes only and should not be considered investment advice. All investments carry risk, including loss of principal. Past performance is not indicative of future results. Consult your licensed financial advisor before making investment decisions.
The Aging Curve Is Doing the Heavy Lifting
You don't need a clever thesis stacked on top of the demographics. The 80-plus population in the U.S. Is on track to nearly double over the next 15 years.
Skilled nursing supply? Shrinking fast. Older facilities close; new construction has effectively stopped because the numbers don't pencil, and the survivors pick up real pricing power.
CareTrust sits right on top of that squeeze. It owns the buildings the industry can't easily replace, and its operators face less competition per zip code than they did five years ago.
Per Jeremy Siegel, the single best-performing original S&P 500 stock from 1957 to 2003 was a…
Two more tailwinds worth flagging:
Medicare Advantage penetration in post-acute care keeps climbing, and the higher-acuity mix is good news for skilled nursing operator economics.
State Medicaid rates have generally trended higher over the last 24 months as states caught up to labor cost inflation. That flows straight into your tenants' ability to pay rent.
The Numbers Behind the Compounding
The math is what turns this from an interesting real estate story into a core holding.
CareTrust has been one of the busiest acquirers in healthcare REIT land two years running. $1.5 billion deployed year-to-date at 8.7% is transformative for a company this size. It grows the earnings base by double digits without cutting anyone in ahead of you.
The balance sheet is the part few talk about enough. Most REITs run leverage in the 5x to 7x zone. CareTrust runs at about 1x. That's roughly $2 to $3 billion of dry powder before it even approaches a normal REIT leverage profile.
In a world where plenty of REITs are net sellers because they can't afford to be buyers, that flexibility is your edge.
Management has also guided conservatively and beaten, over and over. That pattern usually keeps working. Until it doesn't.
The Dividend Story You Actually Get Paid to Own
CareTrust pays $1.27 per share annualized. That works out to a trailing yield around 3.3% at today's price. Not the fattest yield in the REIT universe. And honestly? That's a feature, not a bug.
Two things matter here. First, the payout is well-covered by FFO. You're not white-knuckling every quarterly print, wondering if the distribution gets trimmed.
Second, the growth is real. CareTrust has raised the payout every year since it was spun out in 2014, and the pace has picked up as deployment scaled.
Think of it as an income vehicle. You're clipping 3.3% today, growing at a mid-single-digit clip, backed by a business compounding its asset base north of 15% a year. That's how you end up holding a position paying 6% or 7% on your original cost inside five to seven years.
Action: If you're building an income sleeve, CTRE hits the sweet spot. Yield high enough to matter. Growth fast enough to outrun inflation. Balance sheet clean enough that you actually sleep.
Risks You Need to Own Going In
Nothing here is bulletproof. Three things could break the thesis.
Operator concentration hasn't fully gone away. If a top-five tenant hits trouble, you'll see it in the rent line before anyone else.
CareTrust has diversified hard, but healthcare operators run on thin margins and thin staffing, and a rough quarter from one big tenant will spook the stock.
Reimbursement risk lives in the background. A serious cut to Medicare or Medicaid rates for skilled nursing would squeeze operator coverage ratios, which is what feeds your rent. Washington is quiet on this right now. Don't get complacent.
And rates. If the 10-year keeps drifting above 5%, all REITs get repriced lower on the equity risk premium, fundamentals or not. Your entry price matters. Chasing strength here is a mistake. Building on weakness is the play.
Final Word: Betting on the Boring Compounder
CareTrust isn't a story stock. No AI angle. No crypto exposure. No viral product launch.
What it is: a REIT putting capital out at 8.7% while running almost no leverage, sitting in a sector the market still underestimates, with demographics doing the fundamental work for the next decade.
You get paid better than 3% to wait. The dividend keeps growing. And that Q3 print in late October hands you a near-term catalyst that'll force analysts to redo their models.
Build a position between $36 and $39, and your downside is bounded by a fortress balance sheet while your upside is a multi-year compounder the sell side is still mispricing.
That's the setup. Take it or leave it. I'd rather own this than reach for yield in something with a payout ratio that keeps me up at 3 a.m.
Action Recap
✅ Buy Zone: $36 to $39
✅ Catalysts to Watch: Q3 2026 earnings and guidance update in late October, plus any incremental deployment announcements from the $540M pipeline
✅ Medium-Term Target: $46 to $50 over the next 9 to 12 months if Q3 delivers another guidance bump
✅ Risk Management Tip: Reassess below $34, especially if any top-five tenant flags coverage stress
Setup Scorecard
Entry Zone: $36 to $39
Target: $46 to $50 over 9 to 12 months
Stop Loss: Reassess below $34
Catalyst Timeline: Q3 2026 earnings in late October, additional deployment announcements over Q4
Confidence Level: High. Clean balance sheet, exceptional deployment yields, and the demographics do the fundamental work.
That’s all for today’s edition of the Dividend Brief.
Thanks for reading, and if you have any feedback or dividend stocks you want me to take a look at, just reply to this email!
—Noah Zelvis
DividendBrief.com
